Zobrazeno 1 - 10
of 25
pro vyhledávání: '"John Winkelman"'
Autor:
Michael J. Thorpy, Clete A. Kushida, Richard Bogan, John Winkelman, Maurice M. Ohayon, Colin M. Shapiro, Jennifer Gudeman
Publikováno v:
Sleep Medicine: X, Vol 7, Iss , Pp 100113- (2024)
Background: In the REST-ON clinical trial (NCT02720744), mean sleep latency on the Maintenance of Wakefulness Test (MWT) was significantly improved with extended-release once-nightly sodium oxybate (ON-SXB) vs placebo (P 10 % remained awake for the e
Externí odkaz:
https://doaj.org/article/153529cfb88d475a89cba73df629c87f
Autor:
Ambra Stefani, John Winkelman
Publikováno v:
Frontiers in Sleep, Vol 3 (2024)
Externí odkaz:
https://doaj.org/article/ae120e69d5924e2da1c25c939a1e7a1b
Autor:
Jordana Zackon, John Winkelman
Publikováno v:
SLEEP. 46:A308-A309
Introduction Prior investigations demonstrate a high prevalence of suicidal ideation and behavior in Restless Legs Syndrome (RLS) patients, particularly those with depression and severe RLS symptoms. The present study examines the prevalence of, and
0398 Efficacy of Suvorexant for Insomnia Disorder in Patients with Poorly-Controlled Type 2 Diabetes
Publikováno v:
SLEEP. 46:A176-A176
Introduction Sleep disturbance is a common and underappreciated feature of diabetes and sleep may contribute to glycemic control in patients with type two diabetes (T2D). We conducted a randomized placebo-controlled 3-month trial to examine the effic
Autor:
JOHN WINKELMAN, MAURICE OHAYON, MICHAEL THORPY, DAVID SEIDEN, RICHARD BOGAN, JORDAN DUBOW, COLIN SHAPIRO
Publikováno v:
Chest. 160:A2426-A2428
Publikováno v:
Sleep. 45:A242-A243
Introduction Restless leg syndrome (RLS) is a debilitating condition associated with reduced health-related quality of life (HRQoL) and increased resource utilization. Our objective was to provide model-based estimates of quality-adjusted life year (
Autor:
Christopher Cinatl, William Ondo, Brian Koo, Karla Dzienkowski, Jeffrey Durmer, Charles Phelps, John Winkelman
Publikováno v:
Sleep. 45:A241-A241
Introduction RLS affects 5%-10% of European and North American adults, with 2%-3% experiencing moderate to severe symptoms. RLS patients, often undiagnosed or improperly treated, experience significant depression in addition to loss of sleep. Methods
0407 Early Efficacy With Once-Nightly Sodium Oxybate (ON-SXB; FT218): Post-hoc Analyses From REST-ON
Autor:
Lois Krahn, Asim Roy, John Winkelman, Ann Marie Morse, David Seiden, Jordan Dubow, Jennifer Gudeman
Publikováno v:
Sleep. 45:A182-A182
Introduction Extended-release once-nightly sodium oxybate (ON-SXB; FT218) is in development for adults with narcolepsy. In REST-ON, significant improvements on the Maintenance of Wakefulness test, Clinical Global Impression of Improvement rating, and
Autor:
Irene M. Watts, Julie Dean. Rosati, John. Winkelman, Mitchell E. Brown, Ashley E Frey, Tanya M. Beck, Honghai Li, Mark L. Habel, Edward. O’Donnell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a247126272c99db3d8ff0d962ac75d6b
https://doi.org/10.21079/11681/27405
https://doi.org/10.21079/11681/27405